Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 21, 2017 08:30 ET | Source: Avinger, Inc.

Avinger Announces 510(k) Filing of Next Generation Pantheris Device

REDWOOD CITY, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced the Company submitted...
December 20, 2017 08:30 ET | Source: Avinger, Inc.

Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device

REDWOOD CITY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced Conformité...
December 14, 2017 16:01 ET | Source: Avinger, Inc.

Avinger Secures Waiver and Consent to CRG Loan Agreement

REDWOOD CITY, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...
December 11, 2017 16:15 ET | Source: Avinger, Inc.

Avinger Announces Change in Board Leadership

REDWOOD CITY, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD),...
November 09, 2017 16:01 ET | Source: Avinger, Inc.

Avinger Announces Third Quarter 2017 Results

REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD),...
November 06, 2017 07:30 ET | Source: Avinger, Inc.

Avinger Enters into Common Stock Purchase Agreement for up to $15.0 Million with Lincoln Park Capital

REDWOOD CITY, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced...
October 31, 2017 16:01 ET | Source: Avinger, Inc.

Avinger Receives 510(k) Clearance for Design Modifications to Enhance Performance of Pantheris Image-Guided Atherectomy Device

REDWOOD CITY, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that the...
October 31, 2017 08:00 ET | Source: Avinger, Inc.

Avinger to Announce Third Quarter 2017 Results on November 9, 2017

REDWOOD CITY, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
October 19, 2017 16:01 ET | Source: Avinger, Inc.

Avinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent Restenosis

REDWOOD CITY, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced initiation of...
September 26, 2017 16:01 ET | Source: Avinger Inc

Avinger Receives CE Marking Approval for In-Stent Restenosis Treatment Indication With Pantheris Image-Guided Atherectomy

REDWOOD CITY, Calif., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced Conformité...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right